<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36557705</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>12</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2452</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms10122452</ELocationID><Abstract><AbstractText>Long coronavirus disease-19 (COVID-19) is a newly discovered syndrome characterized by multiple organ manifestations that persist for weeks to months, following the recovery from acute disease. Occasionally, neurological and cardiovascular side effects mimicking long COVID-19 have been reported in recipients of COVID-19 vaccines. Hypothetically, the clinical similarity could be due to a shared pathogenic role of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike (S) protein produced by the virus or used for immunization. The S protein can bind to neuropilin (NRP)-1, which normally functions as a coreceptor for the vascular endothelial growth factor (VEGF)-A. By antagonizing the docking of VEGF-A to NRP-1, the S protein could disrupt physiological pathways involved in angiogenesis and nociception. One consequence could be the increase in unbound forms of VEGF-A that could bind to other receptors. SARS-CoV-2-infected individuals may exhibit increased plasma levels of VEGF-A during both acute illness and convalescence, which could be responsible for diffuse microvascular and neurological damage. A few studies suggest that serum VEGF-A may also be a potential biomarker for long COVID-19, whereas evidence for COVID-19 vaccines is lacking and merits further investigation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Talotta</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8426-1395</Identifier><AffiliationInfo><Affiliation>Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, University Hospital "G. Martino", 98124 Messina, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccine</Keyword><Keyword MajorTopicYN="N">NRP-1</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">VEGF-A</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword><Keyword MajorTopicYN="N">small fiber neuropathy</Keyword><Keyword MajorTopicYN="N">spike protein</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36557705</ArticleId><ArticleId IdType="pmc">PMC9784975</ArticleId><ArticleId IdType="doi">10.3390/microorganisms10122452</ArticleId><ArticleId IdType="pii">microorganisms10122452</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.L., et al. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Coronavirus Disease (COVID-19) Pandemic.  [(accessed on 7 November 2022)].  Available online:  https://www.who.int/europe/emergencies/situations/COVID-19.</Citation></Reference><Reference><Citation>Li X., Wang L., Yan S., Yang F., Xiang L., Zhu J., Shen B., Gong Z. Clinical Characteristics of 25 Death Cases with COVID-19: A Retrospective Review of Medical Records in a Single Medical Center, Wuhan, China. Int. J. Infect. Dis. 2020;94:128&#x2013;132. doi: 10.1016/j.ijid.2020.03.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.053</ArticleId><ArticleId IdType="pmc">PMC7128884</ArticleId><ArticleId IdType="pubmed">32251805</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., Wu Y., Zhang L., Yu Z., Fang M., et al. Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study. Lancet Respir. Med. 2020;8:475&#x2013;481. doi: 10.1016/S2213-2600(20)30079-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Yang C., Xu X.F., Xu W., Liu S.W. Structural and Functional Properties of SARS-CoV-2 Spike Protein: Potential Antivirus Drug Development for COVID-19. Acta Pharmacol. Sin. 2020;41:1141&#x2013;1149. doi: 10.1038/s41401-020-0485-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-0485-4</ArticleId><ArticleId IdType="pmc">PMC7396720</ArticleId><ArticleId IdType="pubmed">32747721</ArticleId></ArticleIdList></Reference><Reference><Citation>Trougakos I.P., Stamatelopoulos K., Terpos E., Tsitsilonis O.E., Aivalioti E., Paraskevis D., Kastritis E., Pavlakis G.N., Dimopoulos M.A. Insights to SARS-CoV-2 Life Cycle, Pathophysiology, and Rationalized Treatments That Target COVID-19 Clinical Complications. J. Biomed. Sci. 2021;28:9. doi: 10.1186/s12929-020-00703-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-00703-5</ArticleId><ArticleId IdType="pmc">PMC7801873</ArticleId><ArticleId IdType="pubmed">33435929</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenizia C., Galbiati S., Vanetti C., Vago R., Clerici M., Tacchetti C., Daniele T. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2. Cells. 2021;10:1434. doi: 10.3390/cells10061434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061434</ArticleId><ArticleId IdType="pmc">PMC8226513</ArticleId><ArticleId IdType="pubmed">34201214</ArticleId></ArticleIdList></Reference><Reference><Citation>Jobe A., Vijayan R. Neuropilins: C-End Rule Peptides and Their Association with Nociception and COVID-19. Comput. Struct. Biotechnol. J. 2021;19:1889&#x2013;1895. doi: 10.1016/j.csbj.2021.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.03.025</ArticleId><ArticleId IdType="pmc">PMC7997051</ArticleId><ArticleId IdType="pubmed">33815686</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleki K., Banazadeh M., Miri N.S., Azadmehr A. Triangle of Cytokine Storm, Central Nervous System Involvement, and Viral Infection in COVID-19: The Role of SFasL and Neuropilin-1. Rev. Neurosci. 2022;33:147&#x2013;160. doi: 10.1515/revneuro-2021-0047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2021-0047</ArticleId><ArticleId IdType="pubmed">34225390</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavan M., Bassani D., Sturlese M., Moro S. From the Wuhan-Hu-1 Strain to the XD and XE Variants: Is Targeting the SARS-CoV-2 Spike Protein Still a Pharmaceutically Relevant Option against COVID-19? J. Enzym. Inhib. Med. Chem. 2022;37:1704&#x2013;1714. doi: 10.1080/14756366.2022.2081847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2022.2081847</ArticleId><ArticleId IdType="pmc">PMC9196651</ArticleId><ArticleId IdType="pubmed">35695095</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari M., Lu R.-M., Li M.-C., Huang J.-L., Hsu F.-F., Ko S.-H., Ke F.-Y., Su S.-C., Liang K.-H., Yuan J.P.-Y., et al. A Critical Overview of Current Progress for COVID-19: Development of Vaccines, Antiviral Drugs, and Therapeutic Antibodies. J. Biomed. Sci. 2022;29:68. doi: 10.1186/s12929-022-00852-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-022-00852-9</ArticleId><ArticleId IdType="pmc">PMC9465653</ArticleId><ArticleId IdType="pubmed">36096815</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappa M., Verdecchia P., Angeli F. Knowing the New Omicron BA.2.75 Variant (&#x2018;Centaurus&#x2019;): A Simulation Study. Eur. J. Intern. Med. 2022;105:107&#x2013;108. doi: 10.1016/j.ejim.2022.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2022.08.009</ArticleId><ArticleId IdType="pmc">PMC9376787</ArticleId><ArticleId IdType="pubmed">35981914</ArticleId></ArticleIdList></Reference><Reference><Citation>Consolazio D., Murtas R., Tunesi S., Lamberti A., Senatore S., Faccini M., Russo A.G. A Comparison Between Omicron and Earlier COVID-19 Variants&#x2019; Disease Severity in the Milan Area, Italy. Front. Epidemiol. 2022;2:891162. doi: 10.3389/fepid.2022.891162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fepid.2022.891162</ArticleId><ArticleId IdType="pmc">PMC10910966</ArticleId><ArticleId IdType="pubmed">38455311</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie B. COVID-19: Early Studies Give Hope Omicron Is Milder than Other Variants. BMJ. 2021;375:n3144. doi: 10.1136/bmj.n3144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n3144</ArticleId><ArticleId IdType="pubmed">34949600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolter N., Jassat W., Walaza S., Welch R., Moultrie H., Groome M., Amoako D.G., Everatt J., Bhiman J.N., Scheepers C., et al. Early Assessment of the Clinical Severity of the SARS-CoV-2 Omicron Variant in South Africa: A Data Linkage Study. Lancet. 2022;399:437&#x2013;446. doi: 10.1016/S0140-6736(22)00017-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00017-4</ArticleId><ArticleId IdType="pmc">PMC8769664</ArticleId><ArticleId IdType="pubmed">35065011</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyengar K.P., Jain V.K., Vaishya R., Ish P. Long COVID-19: An Emerging Pandemic in Itself. Adv. Respir. Med. 2021;89:234&#x2013;236. doi: 10.5603/ARM.a2021.0040.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/ARM.a2021.0040</ArticleId><ArticleId IdType="pubmed">33966266</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of Long COVID Associated with Delta versus Omicron Variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients after Acute COVID-19. JAMA&#x2014;J. Am. Med. Assoc. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or Post-COVID-19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>EudraVigilance&#x2014;European Database of Suspected Adverse Drug Reaction Reports.  [(accessed on 13 October 2022)].  Available online:  https://www.adrreports.eu/en/search_subst.html#.</Citation></Reference><Reference><Citation>SeyedAlinaghi S., Karimi A., Pashaei Z., Afzalian A., Mirzapour P., Ghorbanzadeh K., Ghasemzadeh A., Dashti M., Nazarian N., Vahedi F., et al. Safety and Adverse Events Related to COVID-19 MRNA Vaccines; a Systematic Review. Arch. Acad. Emerg. Med. 2022;10:e41. doi: 10.22037/aaem.v10i1.1597.</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/aaem.v10i1.1597</ArticleId><ArticleId IdType="pmc">PMC9206826</ArticleId><ArticleId IdType="pubmed">35765616</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabail R., Ahmed W., Ilyas M., Rajoka M.S.R., Hassoun A., Khalid A.R., Khan M.R., Aadil R.M. The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization. Vaccines. 2022;10:488. doi: 10.3390/vaccines10040488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10040488</ArticleId><ArticleId IdType="pmc">PMC9031559</ArticleId><ArticleId IdType="pubmed">35455237</ArticleId></ArticleIdList></Reference><Reference><Citation>Khokhar F., Khan A., Hussain Z., Yu J. Small Fiber Neuropathy Associated with the Moderna SARS-CoV-2 Vaccine. Cureus. 2022;14:e25969. doi: 10.7759/cureus.25969.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.25969</ArticleId><ArticleId IdType="pmc">PMC9259076</ArticleId><ArticleId IdType="pubmed">35812635</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A., De Marco G., Mahajna H., Druyan A., Eltity M., Hijazi N., Haddad A., Elias M., Zisman D., Naffaa M.E., et al. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following Mrna/Dna Sars-Cov-2 Vaccination. Vaccines. 2021;9:435. doi: 10.3390/vaccines9050435.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050435</ArticleId><ArticleId IdType="pmc">PMC8146571</ArticleId><ArticleId IdType="pubmed">33946748</ArticleId></ArticleIdList></Reference><Reference><Citation>Schelke M.W., Barcavage S., Lampshire E., Brannagan T.H. Post&#x2013;COVID-19 vaccine small-fiber neuropathy and tinnitus treated with plasma exchange. Muscle Nerve. 2022;66:E21&#x2013;E23. doi: 10.1002/mus.27696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27696</ArticleId><ArticleId IdType="pmc">PMC9537871</ArticleId><ArticleId IdType="pubmed">35934893</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott M.G., Allawi Z., Hofer M., Ansorge O., Brady S., Fadic R., Torres G., Knight R., Calvo M., Bennett D.L.H., et al. Acute small fiber neuropathy after Oxford-AstraZeneca ChAdOx1-S vaccination: A report of three cases and review of the literature. J. Peripher. Nerv. Syst. 2022;27:325&#x2013;329. doi: 10.1111/jns.12509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12509</ArticleId><ArticleId IdType="pmc">PMC9538519</ArticleId><ArticleId IdType="pubmed">35962630</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutal A., Martin L.F., Boinon L., Gomez K., Ran D., Zhou Y., Stratton H.J., Cai S., Luo S., Gonzalez K.B., et al. SARS-CoV-2 Spike Protein Co-Opts VEGF-A/Neuropilin-1 Receptor Signaling to Induce Analgesia. Pain. 2021;162:243&#x2013;252. doi: 10.1097/j.pain.0000000000002097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002097</ArticleId><ArticleId IdType="pmc">PMC7737878</ArticleId><ArticleId IdType="pubmed">33009246</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Miller S., Patek M., Moutal A., Duran P., Cabel C.R., Thorne C.A., Campos S.K., Khanna R. Novel Compounds Targeting Neuropilin Receptor 1 with Potential to Interfere with SARS-CoV-2 Virus Entry. ACS Chem. Neurosci. 2021;12:1299&#x2013;1312. doi: 10.1021/acschemneuro.0c00619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00619</ArticleId><ArticleId IdType="pmc">PMC8029449</ArticleId><ArticleId IdType="pubmed">33787218</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudowska-Sawczuk M., Mroczko B. The Role of Neuropilin-1 (Nrp-1) in Sars-Cov-2 Infection: Review. J. Clin. Med. 2021;10:2772. doi: 10.3390/jcm10132772.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132772</ArticleId><ArticleId IdType="pmc">PMC8267897</ArticleId><ArticleId IdType="pubmed">34202613</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli F., Reboldi G., Trapasso M., Zappa M., Spanevello A., Verdecchia P. COVID-19, Vaccines and Deficiency of ACE2 and Other Angiotensinases. Closing the Loop on the &#x201c;Spike Effect&#x201d;. Eur. J. Intern. Med. 2022;103:23&#x2013;28. doi: 10.1016/j.ejim.2022.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2022.06.015</ArticleId><ArticleId IdType="pmc">PMC9217159</ArticleId><ArticleId IdType="pubmed">35753869</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli F., Spanevello A., Reboldi G., Visca D., Verdecchia P. SARS-CoV-2 Vaccines: Lights and Shadows. Eur. J. Intern. Med. 2021;88:1&#x2013;8. doi: 10.1016/j.ejim.2021.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.04.019</ArticleId><ArticleId IdType="pmc">PMC8084611</ArticleId><ArticleId IdType="pubmed">33966930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos S.G., da Cruz Rattis B.A., Ottaviani G., Celes M.R.N., Dias E.P. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients. Am. J. Pathol. 2021;191:1154&#x2013;1164. doi: 10.1016/j.ajpath.2021.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.04.010</ArticleId><ArticleId IdType="pmc">PMC8099789</ArticleId><ArticleId IdType="pubmed">33964216</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfera A., Osorio C., Jafri N., Diaz E.L., Campo Maldonado J.E. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis. Front. Immunol. 2020;11:1472. doi: 10.3389/fimmu.2020.01472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01472</ArticleId><ArticleId IdType="pmc">PMC7325923</ArticleId><ArticleId IdType="pubmed">32655579</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Hu R., Zhang C., Ren W., Yu A., Zhou X. Elevation of Plasma Angiotensin II Level Is a Potential Pathogenesis for the Critically Ill COVID-19 Patients. Crit. Care. 2020;24:290. doi: 10.1186/s13054-020-03015-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03015-0</ArticleId><ArticleId IdType="pmc">PMC7273814</ArticleId><ArticleId IdType="pubmed">32503680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Huang Y., Zhang J., Xing B., Xuan W., Wang H., Huang H., Yang J., Tang J. NRP-2 in Tumor Lymphangiogenesis and Lymphatic Metastasis. Cancer Lett. 2018;418:176&#x2013;184. doi: 10.1016/j.canlet.2018.01.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2018.01.040</ArticleId><ArticleId IdType="pubmed">29339213</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S., Bag A.K., Singh R.K., Talmadge J.E., Batra S.K., Datta K. Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy. Front. Immunol. 2017;8:1228. doi: 10.3389/fimmu.2017.01228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01228</ArticleId><ArticleId IdType="pmc">PMC5641316</ArticleId><ArticleId IdType="pubmed">29067024</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.D., Zhong L.P., He J., Zhao Y.X. Targeting Neuropilin-1 Interactions Is a Promising Anti-Tumor Strategy. Chin. Med. J. 2021;134:508&#x2013;517. doi: 10.1097/CM9.0000000000001200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000001200</ArticleId><ArticleId IdType="pmc">PMC7929525</ArticleId><ArticleId IdType="pubmed">33177389</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziani G., Lacal P.M. Neuropilin-1 as Therapeutic Target for Malignant Melanoma. Front. Oncol. 2015;5:125. doi: 10.3389/fonc.2015.00125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2015.00125</ArticleId><ArticleId IdType="pmc">PMC4453476</ArticleId><ArticleId IdType="pubmed">26090340</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Acker N., Rag&#xe9; M., Vermeirsch H., Schrijvers D., Nuydens R., Byttebier G., Timmers M., De Schepper S., Streffer J., Andries L., et al. NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy. PLoS ONE. 2016;11:e0161441. doi: 10.1371/journal.pone.0161441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0161441</ArticleId><ArticleId IdType="pmc">PMC5012683</ArticleId><ArticleId IdType="pubmed">27598321</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey N.L. Lymphatic Vascular Development. In: Rosenthal N., Harvey R.P., editors. Heart Development and Regeneration. Elsevier; Amsterdam, The Netherlands: 2010. pp. 543&#x2013;565.</Citation></Reference><Reference><Citation>Schellenburg S., Schulz A., Poitz D.M., Muders M.H. Role of Neuropilin-2 in the Immune System. Mol. Immunol. 2017;90:239&#x2013;244. doi: 10.1016/j.molimm.2017.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2017.08.010</ArticleId><ArticleId IdType="pubmed">28843905</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhu X., Cui H., Shi J., Yuan G., Shi S., Hu Y. The Role of the VEGF Family in Coronary Heart Disease. Front. Cardiovasc. Med. 2021;8:738325. doi: 10.3389/fcvm.2021.738325.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.738325</ArticleId><ArticleId IdType="pmc">PMC8421775</ArticleId><ArticleId IdType="pubmed">34504884</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolard J., Bevan H.S., Harper S.J., Bates D.O. Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity. Microcirculation. 2009;16:572&#x2013;592. doi: 10.1080/10739680902997333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10739680902997333</ArticleId><ArticleId IdType="pmc">PMC2929464</ArticleId><ArticleId IdType="pubmed">19521900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallensten J., Mobarrez F., &#xc5;sberg M., Borg K., Beser A., Wilczek A., Nager A. Isoforms of Soluble Vascular Endothelial Growth Factor in Stress-Related Mental Disorders: A Cross-Sectional Study. Sci. Rep. 2021;11:16693. doi: 10.1038/s41598-021-96313-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96313-8</ArticleId><ArticleId IdType="pmc">PMC8370974</ArticleId><ArticleId IdType="pubmed">34404878</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Chen H., Lu L., Wang L., Zhang X., Guo X. New Insights into the Role of Co-Receptor Neuropilins in Tumour Angiogenesis and Lymphangiogenesis and Targeted Therapy Strategies. J. Drug Target. 2021;29:155&#x2013;167. doi: 10.1080/1061186X.2020.1815210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1061186X.2020.1815210</ArticleId><ArticleId IdType="pubmed">32838575</ArticleId></ArticleIdList></Reference><Reference><Citation>King C., Wirth D., Workman S., Hristova K. Interactions between NRP1 and VEGFR2 Molecules in the Plasma Membrane. Biochim. Biophys. Acta-Biomembr. 2018;1860:2118&#x2013;2125. doi: 10.1016/j.bbamem.2018.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2018.03.023</ArticleId><ArticleId IdType="pmc">PMC6177318</ArticleId><ArticleId IdType="pubmed">29630862</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya M. Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1/Flt-1): A Dual Regulator for Angiogenesis. Angiogenesis. 2006;9:225&#x2013;230. doi: 10.1007/s10456-006-9055-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-006-9055-8</ArticleId><ArticleId IdType="pubmed">17109193</ArticleId></ArticleIdList></Reference><Reference><Citation>Colotti G., Failla C.M., Lacal P.M., Ungarelli M., Ruffini F., Di Micco P., Orecchia A., Morea V. Neuropilin-1 Is Required for Endothelial Cell Adhesion to Soluble Vascular Endothelial Growth Factor Receptor 1. FEBS J. 2022;289:183&#x2013;198. doi: 10.1111/febs.16119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.16119</ArticleId><ArticleId IdType="pmc">PMC9290910</ArticleId><ArticleId IdType="pubmed">34252269</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampropoulou D.I., Bala V.M., Zerva E., Pliakou E., Filippou D., Gazouli M., Aravantinos G. The Potential Role of the Combined PARP-1 and VEGF Inhibition in Severe SARS-CoV-2 (COVID-19) Infection. J. Infect. Dev. Ctries. 2022;16:101&#x2013;111. doi: 10.3855/jidc.15386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.15386</ArticleId><ArticleId IdType="pubmed">35192527</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowacka M.M., Obuchowicz E. Vascular Endothelial Growth Factor (VEGF) and Its Role in the Central Nervous System: A New Element in the Neurotrophic Hypothesis of Antidepressant Drug Action. Neuropeptides. 2012;46:1&#x2013;10. doi: 10.1016/j.npep.2011.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.npep.2011.05.005</ArticleId><ArticleId IdType="pubmed">21719103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulse R.P. Role of VEGF-A in Chronic Pain. Oncotarget. 2017;8:10775&#x2013;10776. doi: 10.18632/oncotarget.14615.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14615</ArticleId><ArticleId IdType="pmc">PMC5355219</ArticleId><ArticleId IdType="pubmed">28099925</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukouyama Y.S., Gerber H.P., Ferrara N., Gu C., Anderson D.J. Peripheral Nerve-Derived VEGF Promotes Arterial Differentiation via Neuropilin 1-Mediated Positive Feedback. Development. 2005;132:941&#x2013;952. doi: 10.1242/dev.01675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.01675</ArticleId><ArticleId IdType="pubmed">15673567</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuch G., Machluf M., Bartsch G., Nomi M., Richard H., Atala A., Soker S. In Vivo Administration of Vascular Endothelial Growth Factor (VEGF) and Its Antagonist, Soluble Neuropilin-1, Predicts a Role of VEGF in the Progression of Acute Myeloid Leukemia in Vivo. Blood. 2002;100:4622&#x2013;4628. doi: 10.1182/blood.V100.13.4622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V100.13.4622</ArticleId><ArticleId IdType="pubmed">12453880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Zhang L., Xiao Z., Lu S., Yang R., Han Z.C. Neuropilin-1 in Acute Myeloid Leukemia: Expression and Role in Proliferation and Migration of Leukemia Cells. Leuk. Lymphoma. 2008;49:331&#x2013;338. doi: 10.1080/10428190701809149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10428190701809149</ArticleId><ArticleId IdType="pubmed">18231921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffini F., D&#x2019;Atri S., Lacal P.M. Neuropilin-1 Expression Promotes Invasiveness of Melanoma Cells through Vascular Endothelial Growth Factor Receptor-2-Dependent and -Independent Mechanisms. Int. J. Oncol. 2013;43:297&#x2013;306. doi: 10.3892/ijo.2013.1948.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2013.1948</ArticleId><ArticleId IdType="pubmed">23685409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.W., Lee J.E., Yoo C.Y., Ko M.S., Park C.S., Yang S.H. NRP-1 Expression Is Strongly Associated with the Progression of Pituitary Adenomas. Oncol. Rep. 2014;32:1537&#x2013;1542. doi: 10.3892/or.2014.3392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2014.3392</ArticleId><ArticleId IdType="pubmed">25109698</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M., Hou L., Li J., Shao S., Huang S., Meng D., Liu L., Feng L., Xia P., Qin T., et al. VEGF/NRP-1axis Promotes Progression of Breast Cancer via Enhancement of Epithelial-Mesenchymal Transition and Activation of NF-&#x39a;B and &#x3b2;-Catenin. Cancer Lett. 2016;373:1&#x2013;11. doi: 10.1016/j.canlet.2016.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2016.01.010</ArticleId><ArticleId IdType="pubmed">26805761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Jiang X. Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis. Target. Oncol. 2016;11:501&#x2013;505. doi: 10.1007/s11523-016-0422-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11523-016-0422-0</ArticleId><ArticleId IdType="pubmed">26916409</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia J., Hurwitz H.I., Sandler A.B., Miles D., Coleman R.L., Deurloo R., Chinot O.L. Bevacizumab (Avastin&#xae;) in Cancer Treatment: A Review of 15 Years of Clinical Experience and Future Outlook. Cancer Treat. Rev. 2020;86:102017. doi: 10.1016/j.ctrv.2020.102017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2020.102017</ArticleId><ArticleId IdType="pubmed">32335505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Cao Y., Yamada S., Thirunavukkarasu M., Nin V., Joshi M., Rishi M.T., Bhattacharya S., Camacho-Pereira J., Sharma A.K., et al. Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-&#x3b1; Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1&#x3b1; and Mitochondrial Homeostasis. Arterioscler. Thromb. Vasc. Biol. 2015;35:1401&#x2013;1412. doi: 10.1161/ATVBAHA.115.305566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.115.305566</ArticleId><ArticleId IdType="pmc">PMC4441604</ArticleId><ArticleId IdType="pubmed">25882068</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wang E., Zhang Y., Madamsetty V.S., Ji B., Radisky D.C., Grande J.P., Misra S., Mukhopadhyay D. Neuropilin-1 Maintains Dimethylarginine Dimethylaminohydrolase 1 Expression in Endothelial Cells, and Contributes to Protection from Angiotensin II-Induced Hypertension. FASEB J. 2019;33:494&#x2013;500. doi: 10.1096/fj.201800499R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201800499R</ArticleId><ArticleId IdType="pmc">PMC6355070</ArticleId><ArticleId IdType="pubmed">30118322</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa C., Mart&#xed;nez-S&#xe1;ez E., Guti&#xe9;rrez-Franco A., Eixarch H., Castro Z., Ortega-Aznar A., Ram&#xf3;n Y.C.S., Montalban X., Espejo C. Expression of Semaphorin 3A, Semaphorin 7A and Their Receptors in Multiple Sclerosis Lesions. Mult. Scler. 2015;21:1632&#x2013;1643. doi: 10.1177/1352458515599848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458515599848</ArticleId><ArticleId IdType="pubmed">26432853</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomona B.D., Muellera C., Chaeb W.J., Alabanzaa L.M., Bynoea M.S. Neuropilin-1 Attenuates Autoreactivity in Experimental Autoimmune Encephalomyelitis. Proc. Natl. Acad. Sci. USA. 2011;108:2040&#x2013;2045. doi: 10.1073/pnas.1008721108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008721108</ArticleId><ArticleId IdType="pmc">PMC3033275</ArticleId><ArticleId IdType="pubmed">21245328</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissen J.C., Tsirka S.E. Tuftsin-Driven Experimental Autoimmune Encephalomyelitis Recovery Requires Neuropilin-1. Glia. 2016;64:923&#x2013;936. doi: 10.1002/glia.22972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22972</ArticleId><ArticleId IdType="pmc">PMC4833601</ArticleId><ArticleId IdType="pubmed">26880314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollock C.E., Sutherland H.G., Maher B.H., Lea R.A., Haupt L.M., Frith A., Anne MacGregor E., Griffiths L.R. The NRP1 Migraine Risk Variant Shows Evidence of Association with Menstrual Migraine. J. Headache Pain. 2018;19:31. doi: 10.1186/s10194-018-0857-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-018-0857-z</ArticleId><ArticleId IdType="pmc">PMC5906416</ArticleId><ArticleId IdType="pubmed">29671086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali T., Qazilbash M.H. POEMS Syndrome: A Multisystem Clonal Disorder. Eur. J. Haematol. 2021;106:14&#x2013;18. doi: 10.1111/ejh.13514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejh.13514</ArticleId><ArticleId IdType="pubmed">32889731</ArticleId></ArticleIdList></Reference><Reference><Citation>Dispenzieri A. POEMS Syndrome: 2021 Update on Diagnosis, Risk-Stratification, and Management. Am. J. Hematol. 2021;96:872&#x2013;888. doi: 10.1002/ajh.26240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26240</ArticleId><ArticleId IdType="pubmed">34000085</ArticleId></ArticleIdList></Reference><Reference><Citation>Arima K., Origuchi T., Tamai M., Iwanaga N., Izumi Y., Huang M., Tanaka F., Kamachi M., Aratake K., Nakamura H., et al. RS3PE Syndrome Presenting as Vascular Endothelial Growth Factor Associated Disorder. Ann. Rheum. Dis. 2005;64:1653&#x2013;1655. doi: 10.1136/ard.2004.032995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2004.032995</ArticleId><ArticleId IdType="pmc">PMC1755286</ArticleId><ArticleId IdType="pubmed">16227418</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets P., Devauchelle-Pensec V., Rouzaire P.O., Pereira B., Andre M., Soubrier M. Vascular Endothelial Growth Factor Levels and Rheumatic Diseases of the Elderly. Arthritis Res. Ther. 2016;18:283. doi: 10.1186/s13075-016-1184-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-016-1184-x</ArticleId><ArticleId IdType="pmc">PMC5133736</ArticleId><ArticleId IdType="pubmed">27906058</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada M., Mitsuyama K., Yoshida H., Sakisaka S., Taniguchi E., Kawaguchi T., Ariyoshi M., Saiki T., Sakamoto M., Nagata K., et al. Vascular Endothelial Growth Factor in Patients with Rheumatoid Arthritis. Scand. J. Rheumatol. 1998;27:377&#x2013;380. doi: 10.1080/03009749850154429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03009749850154429</ArticleId><ArticleId IdType="pubmed">9808403</ArticleId></ArticleIdList></Reference><Reference><Citation>Meliconi R., Pulsatelli L., Dolzani P., Boiardi L., Macchioni P., Salvarani C., Silvestri T., Frizziero L., Facchini A. Vascular Endothelial Growth Factor Production in Polymyalgia Rheumatica. Arthritis Rheum. 2000;43:2472&#x2013;2480. doi: 10.1002/1529-0131(200011)43:11&lt;2472::AID-ANR14&gt;3.0.CO;2-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200011)43:11&lt;2472::AID-ANR14&gt;3.0.CO;2-B</ArticleId><ArticleId IdType="pubmed">11083270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert S., Bouttier M., Vassy R., Seigneuret M., Petrow-Sadowski C., Janvier S., Heveker N., Ruscetti F.W., Perret G., Jones K.S., et al. HTLV-1 Uses HSPG and Neuropilin-1 for Entry by Molecular Mimicry of VEGF165. Blood. 2009;113:5176&#x2013;5185. doi: 10.1182/blood-2008-04-150342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-04-150342</ArticleId><ArticleId IdType="pmc">PMC2686187</ArticleId><ArticleId IdType="pubmed">19270265</ArticleId></ArticleIdList></Reference><Reference><Citation>Afonso P.V., Ozden S., Cumont M.C., Seilhean D., Cartier L., Rezaie P., Mason S., Lambert S., Huerre M., Gessain A., et al. Alteration of Blood-Brain Barrier Integrity by Retroviral Infection. PLoS Pathog. 2008;4:e1000205. doi: 10.1371/journal.ppat.1000205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000205</ArticleId><ArticleId IdType="pmc">PMC2575404</ArticleId><ArticleId IdType="pubmed">19008946</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeberle H.A., D&#xfc;rrstein C., Rosenberger P., Hosakote Y.M., Kuhlicke J., Kempf V.A.J., Garofalo R.P., Eitzschig H.K. Oxygen-Independent Stabilization of Hypoxia Inducible Factor (HIF)-1 during RSV Infection. PLoS ONE. 2008;3:e3352. doi: 10.1371/journal.pone.0003352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003352</ArticleId><ArticleId IdType="pmc">PMC2556398</ArticleId><ArticleId IdType="pubmed">18839041</ArticleId></ArticleIdList></Reference><Reference><Citation>Morichi S., Morishita N., Takeshita M., Ishida Y., Oana S., Yamanaka G., Kashiwagi Y., Kawashima H. Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF) Levels in the Cerebrospinal Fluid of Children with Influenza-Associated Encephalopathy. J. Infect. Chemother. 2017;23:80&#x2013;84. doi: 10.1016/j.jiac.2016.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2016.10.007</ArticleId><ArticleId IdType="pubmed">27887787</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkharsah K.R. VEGF Upregulation in Viral Infections and Its Possible Therapeutic Implications. Int. J. Mol. Sci. 2018;19:1642. doi: 10.3390/ijms19061642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19061642</ArticleId><ArticleId IdType="pmc">PMC6032371</ArticleId><ArticleId IdType="pubmed">29865171</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.S., Oshansky C.M., Guo X.Z.J., Ralston J., Wood T., Seeds R., Newbern C., Waite B., Reynolds G., Widdowson M.A., et al. Severe Influenza Is Characterized by Prolonged Immune Activation: Results from the SHIVERS Cohort Study. J. Infect. Dis. 2018;217:245&#x2013;256. doi: 10.1093/infdis/jix571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix571</ArticleId><ArticleId IdType="pmc">PMC7335675</ArticleId><ArticleId IdType="pubmed">29112724</ArticleId></ArticleIdList></Reference><Reference><Citation>Bautista E., Arcos M., Jimenez-Alvarez L., Garc&#xed;a-Sancho M.C., V&#xe1;zquez M.E., Pe&#xf1;a E., Higuera A., Ram&#xed;rez G., Fern&#xe1;ndez-Plata R., Cruz-Lagunas A., et al. Angiogenic and Inflammatory Markers in Acute Respiratory Distress Syndrome and Renal Injury Associated to A/H1N1 Virus Infection. Exp. Mol. Pathol. 2013;94:486&#x2013;492. doi: 10.1016/j.yexmp.2013.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2013.03.007</ArticleId><ArticleId IdType="pubmed">23542734</ArticleId></ArticleIdList></Reference><Reference><Citation>Pino M., Kelvin D.J., Bermejo-Martin J.F., Alonso A., Mat&#xed;as V., Tenorio A., Rico L., Eiros J.M., Castrodeza J., Blanco-Quiros A., et al. Nasopharyngeal Aspirate Cytokine Levels 1 Yr after Severe Respiratory Syncytial Virus Infection. Pediatr. Allergy Immunol. 2009;20:791&#x2013;795. doi: 10.1111/j.1399-3038.2009.00868.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2009.00868.x</ArticleId><ArticleId IdType="pubmed">19302175</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin J.F., Garcia-Arevalo M.C., De Lejarazu R.O., Ardura J., Eiros J.M., Alonso A., Mat&#xed;as V., Pino M., Bernardo D., Arranz E., et al. Predominance of Th2 Cytokines, CXC Chemokines and Innate Immunity Mediators at the Mucosal Level during Severe Respiratory Syncytial Virus Infection in Children. Eur. Cytokine Netw. 2007;18:162&#x2013;167. doi: 10.1684/ecn.2007.0096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/ecn.2007.0096</ArticleId><ArticleId IdType="pubmed">17823085</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmatpanah F., Agrawal S., Jaiswal N., Ngyuen H.M., McClelland M., Agrawal A. Airway Epithelial Cells Prime Plasmacytoid Dendritic Cells to Respond to Pathogens via Secretion of Growth Factors. Mucosal Immunol. 2019;12:77&#x2013;84. doi: 10.1038/s41385-018-0097-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-018-0097-1</ArticleId><ArticleId IdType="pmc">PMC6301110</ArticleId><ArticleId IdType="pubmed">30279511</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldford S.A., Salsman S.P., Portales-Cervantes L., Alyazidi R., Anderson R., Haidl I.D., Marshall J.S. Interferon A2 and Interferon &#x3b3; Induce the Degranulation Independent Production of VEGF-A and IL-1 Receptor Antagonist and Other Mediators from Human Mast Cells. Immun. Inflamm. Dis. 2018;6:176&#x2013;189. doi: 10.1002/iid3.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.211</ArticleId><ArticleId IdType="pmc">PMC5818443</ArticleId><ArticleId IdType="pubmed">29235261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.G., Yoon H.J., Zhu Z., Link H., Wang Z., Gwaltney J., Landry M., Elias J.A. Respiratory Syncytial Virus Stimulation of Vascular Endothelial Cell Growth Factor/Vascular Permeability Factor. Am. J. Respir. Cell Mol. Biol. 2000;23:662&#x2013;669. doi: 10.1165/ajrcmb.23.5.4188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/ajrcmb.23.5.4188</ArticleId><ArticleId IdType="pubmed">11062145</ArticleId></ArticleIdList></Reference><Reference><Citation>Killerby M.E., Biggs H.M., Haynes A., Dahl R.M., Mustaquim D., Gerber S.I., Watson J.T. Human Coronavirus Circulation in the United States 2014&#x2013;2017. J. Clin. Virol. 2018;101:52&#x2013;56. doi: 10.1016/j.jcv.2018.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.019</ArticleId><ArticleId IdType="pmc">PMC7106380</ArticleId><ArticleId IdType="pubmed">29427907</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan A.A., Al-Ahmed S.H., Haque S., Sah R., Tiwari R., Malik Y.S., Dhama K., Yatoo M.I., Bonilla-Aldana D.K., Rodriguez-Morales A.J. SARS-CoV-2, SARS-CoV, and MERS-CoV: A Comparative Overview. Infez. Med. 2020;28:174&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">32275259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed M.E.A. The Percentages of SARS-CoV-2 Protein Similarity and Identity with SARS-CoV and BatCoV RaTG13 Proteins Can Be Used as Indicators of Virus Origin. J. Proteins Proteom. 2021;12:81&#x2013;91. doi: 10.1007/s42485-021-00060-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42485-021-00060-3</ArticleId><ArticleId IdType="pmc">PMC8033097</ArticleId><ArticleId IdType="pubmed">33850392</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L., He Y., Zhou Y., Liu S., Zheng B.J., Jiang S. The Spike Protein of SARS-CoV&#x2014;A Target for Vaccine and Therapeutic Development. Nat. Rev. Microbiol. 2009;7:226&#x2013;236. doi: 10.1038/nrmicro2090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2090</ArticleId><ArticleId IdType="pmc">PMC2750777</ArticleId><ArticleId IdType="pubmed">19198616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatmal M.M., Alshaer W., Al-Hatamleh M.A.I., Hatmal M., Smadi O., Taha M.O., Oweida A.J., Boer J.C., Mohamud R., Plebanski M. Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2. Cells. 2020;9:2638. doi: 10.3390/cells9122638.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9122638</ArticleId><ArticleId IdType="pmc">PMC7763676</ArticleId><ArticleId IdType="pubmed">33302501</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan A.A., Bazzi A.M., Al-Ahmed S.H., Al-Tawfiq J.A. Molecular Aspects of MERS-CoV. Front. Med. 2017;11:365&#x2013;377. doi: 10.1007/s11684-017-0521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-017-0521-z</ArticleId><ArticleId IdType="pmc">PMC7089120</ArticleId><ArticleId IdType="pubmed">28500431</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma J., Subbarao N. A Comparative Study of Human Betacoronavirus Spike Proteins: Structure, Function and Therapeutics. Arch. Virol. 2021;166:697&#x2013;714. doi: 10.1007/s00705-021-04961-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-04961-y</ArticleId><ArticleId IdType="pmc">PMC7821988</ArticleId><ArticleId IdType="pubmed">33483791</ArticleId></ArticleIdList></Reference><Reference><Citation>Millet J.K., Jaimes J.A., Whittaker G.R. Molecular Diversity of Coronavirus Host Cell Entry Receptors. FEMS Microbiol. Rev. 2021;45:fuaa057. doi: 10.1093/femsre/fuaa057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuaa057</ArticleId><ArticleId IdType="pmc">PMC7665467</ArticleId><ArticleId IdType="pubmed">33118022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh P., Jayaram S., Patwardhan D., Marimuthu S., Lenehan P., Venkatakrishnan A., Hughes T., Zemmour D., Anand P., Soundararajan V. Diversity of Coronavirus Receptors. Preprints. 2021:2021080071. doi: 10.20944/preprints202108.0071.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202108.0071.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Talotta R., Robertson E. Autoimmunity as the Comet Tail of COVID-19 Pandemic. World J. Clin. Cases. 2020;8:3621&#x2013;3644. doi: 10.12998/wjcc.v8.i17.3621.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v8.i17.3621</ArticleId><ArticleId IdType="pmc">PMC7479552</ArticleId><ArticleId IdType="pubmed">32953841</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Place S., Van Laethem Y., Cabaraux P., Mat Q., Huet K., Plzak J., Horoi M., Hans S., et al. Clinical and Epidemiological Characteristics of 1420 European Patients with Mild-to-Moderate Coronavirus Disease 2019. J. Intern. Med. 2020;288:335&#x2013;344. doi: 10.1111/joim.13089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13089</ArticleId><ArticleId IdType="pmc">PMC7267446</ArticleId><ArticleId IdType="pubmed">32352202</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes E.K., Zambrano L.D., Anderson K.N., Marder E.P., Raz K.M., El Burai Felix S., Tie Y., Fullerton K.E. Coronavirus Disease 2019 Case Surveillance&#x2014;United States, January 22&#x2013;May 30 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:759&#x2013;765. doi: 10.15585/mmwr.mm6924e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6924e2</ArticleId><ArticleId IdType="pmc">PMC7302472</ArticleId><ArticleId IdType="pubmed">32555134</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B., Carius B.M., Chavez S., Liang S.Y., Brady W.J., Koyfman A., Gottlieb M. Clinical Update on COVID-19 for the Emergency Clinician: Presentation and Evaluation. Am. J. Emerg. Med. 2022;54:46&#x2013;57. doi: 10.1016/j.ajem.2022.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2022.01.028</ArticleId><ArticleId IdType="pmc">PMC8779861</ArticleId><ArticleId IdType="pubmed">35121478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z., Yang K.Y., Huang Y., Lui K.O. Endothelial Contribution to COVID-19: An Update on Mechanisms and Therapeutic Implications. J. Mol. Cell. Cardiol. 2022;164:69&#x2013;82. doi: 10.1016/j.yjmcc.2021.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2021.11.010</ArticleId><ArticleId IdType="pmc">PMC8610843</ArticleId><ArticleId IdType="pubmed">34838588</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulli A., Gotelli E., Bica P.F., Schiavetti I., Pizzorni C., Alo&#xe8; T., Grosso M., Barisione E., Paolino S., Smith V., et al. Detailed Videocapillaroscopic Microvascular Changes Detectable in Adult COVID-19 Survivors. Microvasc. Res. 2022;142:104361. doi: 10.1016/j.mvr.2022.104361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2022.104361</ArticleId><ArticleId IdType="pmc">PMC8942583</ArticleId><ArticleId IdType="pubmed">35339493</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;akmak F., Demirbuga A., Demirkol D., G&#xfc;m&#xfc;&#x15f; S., Torun S.H., Kayaalp G.K., &#xd6;meroglu R.E., Somer A., Uysalol M., Y&#x131;ld&#x131;z R., et al. Nailfold Capillaroscopy: A Sensitive Method for Evaluating Microvascular Involvement in Children with SARS-CoV-2 Infection. Microvasc. Res. 2021;138:104196. doi: 10.1016/j.mvr.2021.104196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2021.104196</ArticleId><ArticleId IdType="pmc">PMC8190529</ArticleId><ArticleId IdType="pubmed">34097919</ArticleId></ArticleIdList></Reference><Reference><Citation>Natalello G., De Luca G., Gigante L., Campochiaro C., De Lorenzis E., Verardi L., Paglionico A., Petricca L., Martone A.M., Calvisi S., et al. Nailfold Capillaroscopy Findings in Patients with Coronavirus Disease 2019: Broadening the Spectrum of COVID-19 Microvascular Involvement. Microvasc. Res. 2021;133:104071. doi: 10.1016/j.mvr.2020.104071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2020.104071</ArticleId><ArticleId IdType="pmc">PMC7494493</ArticleId><ArticleId IdType="pubmed">32949574</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A., Osiaevi I., Buscher K., Sackarnd J., Tepasse P.R., Fobker M., K&#xfc;hn J., Braune S., G&#xf6;bel U., Th&#xf6;lking G., et al. Microvascular Dysfunction in COVID-19: The MYSTIC Study. Angiogenesis. 2021;24:145&#x2013;157. doi: 10.1007/s10456-020-09753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09753-7</ArticleId><ArticleId IdType="pmc">PMC7556767</ArticleId><ArticleId IdType="pubmed">33058027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J., Puan K.J., Wang L.W., Teng K.W.W., Loh C.Y., Tan K.P., Carissimo G., Chan Y.H., Poh C.M., Lee C.Y.P., et al. Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals. Front. Immunol. 2021;12:710217. doi: 10.3389/fimmu.2021.710217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.710217</ArticleId><ArticleId IdType="pmc">PMC8640498</ArticleId><ArticleId IdType="pubmed">34867943</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros T., Guimar&#xe3;es G.M.C., Carvalho F.R., Alves L.S., Faustino R., Campi-Azevedo A.C., Peruhype-Magalh&#xe3;es V., Teixeira-Carvalho A., de Souza Gomes M., Rodrigues do Amaral L., et al. Acute Kidney Injury Associated to COVID-19 Leads to a Strong Unbalance of Circulant Immune Mediators. Cytokine. 2022;157:155974. doi: 10.1016/j.cyto.2022.155974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.155974</ArticleId><ArticleId IdType="pmc">PMC9309102</ArticleId><ArticleId IdType="pubmed">35907365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Meini S., Giani T., Tascini C. Intussusceptive Angiogenesis in COVID-19: Hypothesis on the Significance and Focus on the Possible Role of FGF2. Mol. Biol. Rep. 2020;47:8301&#x2013;8304. doi: 10.1007/s11033-020-05831-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05831-7</ArticleId><ArticleId IdType="pmc">PMC7486971</ArticleId><ArticleId IdType="pubmed">32920756</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja D.M., Mentzer S.J., Fontenay M., Laffan M.A., Ackermann M., Helms J., Jonigk D., Chocron R., Pier G.B., Gendron N., et al. COVID-19 Is a Systemic Vascular Hemopathy: Insight for Mechanistic and Clinical Aspects. Angiogenesis. 2021;24:755&#x2013;788. doi: 10.1007/s10456-021-09805-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09805-6</ArticleId><ArticleId IdType="pmc">PMC8238037</ArticleId><ArticleId IdType="pubmed">34184164</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayi B.S., Leibowitz J.A., Woods A.T., Ammon K.A., Liu A.E., Raja A. The Role of Neuropilin-1 in COVID-19. PLoS Pathog. 2021;17:e1009153. doi: 10.1371/journal.ppat.1009153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009153</ArticleId><ArticleId IdType="pmc">PMC7781380</ArticleId><ArticleId IdType="pubmed">33395426</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipoor S.D., Mirsaeidi M. SARS-CoV-2 Cell Entry beyond the ACE2 Receptor. Mol. Biol. Rep. 2022;49:10715&#x2013;10727. doi: 10.1007/s11033-022-07700-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07700-x</ArticleId><ArticleId IdType="pmc">PMC9244107</ArticleId><ArticleId IdType="pubmed">35754059</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetti B., Daly J.L., Sim&#xf3;n-Gracia L., Klein K., Weeratunga S., Ant&#xf3;n-Pl&#xe1;garo C., Tobi A., Hodgson L., Lewis P.A., Heesom K.J., et al. ESCPE-1 Mediates Retrograde Endosomal Sorting of the SARS-CoV-2 Host Factor Neuropilin-1. Proc. Natl. Acad. Sci. USA. 2022;119:e2201980119. doi: 10.1073/pnas.2201980119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2201980119</ArticleId><ArticleId IdType="pmc">PMC9231623</ArticleId><ArticleId IdType="pubmed">35696571</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Mei H., Sun J., Li H., Huang Y., Tang Y., Duan L., Liu D., Pang Y., Wang Q., et al. Neuropilin-1-Mediated SARS-CoV-2 Infection in Bone Marrow-Derived Macrophages Inhibits Osteoclast Differentiation. Adv. Biol. 2022;6:2200007. doi: 10.1002/adbi.202200007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adbi.202200007</ArticleId><ArticleId IdType="pmc">PMC9073998</ArticleId><ArticleId IdType="pubmed">35195371</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F., Silvestri G., Mavian C., Weichseldorfer M., Munawwar A., Cash M.N., Dulcey M., Vittor A.Y., Ciccozzi M., Salemi M., et al. Comparison of Sars-Cov-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells. Viruses. 2021;13:2193. doi: 10.3390/v13112193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112193</ArticleId><ArticleId IdType="pmc">PMC8620655</ArticleId><ArticleId IdType="pubmed">34834998</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Li W., Feng J., da Silva S.R., Ju E., Zhang H., Chang Y., Moore P.S., Guo H., Gao S.J. SARS-CoV-2 Pseudovirus Infectivity and Expression of Viral Entry-Related Factors ACE2, TMPRSS2, Kim-1, and NRP-1 in Human Cells from the Respiratory, Urinary, Digestive, Reproductive, and Immune Systems. J. Med. Virol. 2021;93:6671&#x2013;6685. doi: 10.1002/jmv.27244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27244</ArticleId><ArticleId IdType="pmc">PMC8426707</ArticleId><ArticleId IdType="pubmed">34324210</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldrid C., Zloh M., Fotinou C., Yelland T., Yu L., Mota F., Selwood D.L., Djordjevic S. VEGFA, B, C: Implications of the C-Terminal Sequence Variations for the Interaction with Neuropilins. Biomolecules. 2022;12:372. doi: 10.3390/biom12030372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12030372</ArticleId><ArticleId IdType="pmc">PMC8945599</ArticleId><ArticleId IdType="pubmed">35327564</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z.-L., Buck M. Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein S1 and S2. Biophys. J. 2021;120:2828&#x2013;2837. doi: 10.1016/j.bpj.2021.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.026</ArticleId><ArticleId IdType="pmc">PMC8169233</ArticleId><ArticleId IdType="pubmed">34087218</ArticleId></ArticleIdList></Reference><Reference><Citation>Baindara P., Roy D., Mandal S.M., Schrum A.G. Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis. Infect. Dis. Rep. 2022;14:243&#x2013;249. doi: 10.3390/idr14020029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr14020029</ArticleId><ArticleId IdType="pmc">PMC9024780</ArticleId><ArticleId IdType="pubmed">35447881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong W., Montano M., Corley M.J., Helmy E., Kobayashi H., Kinisu M., Suryawanshi R., Luo X., Royer L.A., Roan N.R., et al. Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons. mBio. 2022:e0230822. doi: 10.1128/mbio.02308-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02308-22</ArticleId><ArticleId IdType="pmc">PMC9765283</ArticleId><ArticleId IdType="pubmed">36314791</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary J.K., Yadav R., Chaudhary P.K., Maurya A., Roshan R., Azam F., Mehta J., Handu S., Prasad R., Jain N., et al. Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets. Cells. 2021;10:2427. doi: 10.3390/cells10092427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10092427</ArticleId><ArticleId IdType="pmc">PMC8467010</ArticleId><ArticleId IdType="pubmed">34572076</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E.J., Chou S.H.Y., Coles A.J., Menon D.K. Neurological Implications of COVID-19 Infections. Neurocrit. Care. 2020;32:667&#x2013;671. doi: 10.1007/s12028-020-00978-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-020-00978-4</ArticleId><ArticleId IdType="pmc">PMC7188454</ArticleId><ArticleId IdType="pubmed">32346843</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangos M., Budde H., Kolijn D., Sieme M., Zhazykbayeva S., L&#xf3;di M., Herwig M., G&#xf6;m&#xf6;ri K., Hassoun R., Robinson E.L., et al. SARS-CoV-2 Infects Human Cardiomyocytes Promoted by Inflammation and Oxidative Stress. Int. J. Cardiol. 2022;362:196&#x2013;205. doi: 10.1016/j.ijcard.2022.05.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.05.055</ArticleId><ArticleId IdType="pmc">PMC9132721</ArticleId><ArticleId IdType="pubmed">35643215</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezache L., Struckman H.L., Greer-Short A., Baine S., Gy&#xf6;rke S., Radwa&#x144;ski P.B., Hund T.J., Veeraraghavan R. Vascular Endothelial Growth Factor Promotes Atrial Arrhythmias by Inducing Acute Intercalated Disk Remodeling. Sci. Rep. 2020;10:20463. doi: 10.1038/s41598-020-77562-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77562-5</ArticleId><ArticleId IdType="pmc">PMC7687901</ArticleId><ArticleId IdType="pubmed">33235263</ArticleId></ArticleIdList></Reference><Reference><Citation>Chore&#xf1;o-Parra J.A., Jim&#xe9;nez-&#xc1;lvarez L.A., Cruz-Lagunas A., Rodr&#xed;guez-Reyna T.S., Ram&#xed;rez-Mart&#xed;nez G., Sandoval-Vega M., Hern&#xe1;ndez-Garc&#xed;a D.L., Chore&#xf1;o-Parra E.M., Balderas-Mart&#xed;nez Y.I., Martinez-S&#xe1;nchez M.E., et al. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1) Front. Immunol. 2021;12:593595. doi: 10.3389/fimmu.2021.593595.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.593595</ArticleId><ArticleId IdType="pmc">PMC8115405</ArticleId><ArticleId IdType="pubmed">33995342</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z.Z., Chen D.P., Liu Q.B., Gan C., Jiang L., Zhu K., Zhang X.Y., Xu H.M., Huang A.L., Long Q.X., et al. Clinical Features of Chinese Children with COVID-19 and Other Viral Respiratory Infections. Pediatr. Pulmonol. 2022;57:49&#x2013;56. doi: 10.1002/ppul.25700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25700</ArticleId><ArticleId IdType="pmc">PMC8661675</ArticleId><ArticleId IdType="pubmed">34559474</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J., Xu F., Aondio G., Li Y., Fumagalli A., Lu M., Valmadre G., Wei J., Bian Y., Canesi M., et al. Efficacy and Tolerability of Bevacizumab in Patients with Severe COVID-19. Nat. Commun. 2021;12:814. doi: 10.1038/s41467-021-21085-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21085-8</ArticleId><ArticleId IdType="pmc">PMC7864918</ArticleId><ArticleId IdType="pubmed">33547300</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoute H., Elkarhat Z., Elkhattabi L., El Fahime E., Oukkache N., Rouba H., Barakat A. Computational Screening of Potential Drugs against COVID-19 Disease: The Neuropilin-1 Receptor as Molecular Target. VirusDisease. 2022;33:23&#x2013;31. doi: 10.1007/s13337-021-00751-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-021-00751-x</ArticleId><ArticleId IdType="pmc">PMC8776366</ArticleId><ArticleId IdType="pubmed">35079600</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Miller S., Patek M., Moutal A., Cabel C.R., Thorne C.A., Campos S.K., Khanna R. In Silico Identification and Validation of Inhibitors of the Interaction between Neuropilin Receptor 1 and SARS-CoV-2 Spike Protein. bioRxiv. 2020 doi: 10.1101/2020.09.22.308783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.22.308783</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshee S., Vatti N., Chang C. Long-Term Effects of COVID-19. Mayo Clin. Proc. 2022;97:579&#x2013;599. doi: 10.1016/j.mayocp.2021.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.12.017</ArticleId><ArticleId IdType="pmc">PMC8752286</ArticleId><ArticleId IdType="pubmed">35246288</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a Prospective Cohort of Home-Isolated Patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S., Tymoszuk P., Ausserhofer D., Rass V., Pizzini A., Nordmeyer G., H&#xfc;fner K., Kurz K., Weber P.M., Sonnweber T., et al. Phenotyping of Acute and Persistent Coronavirus Disease 2019 Features in the Outpatient Setting: Exploratory Analysis of an International Cross-Sectional Online Survey. Clin. Infect. Dis. 2022;75:e418&#x2013;e431. doi: 10.1093/cid/ciab978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab978</ArticleId><ArticleId IdType="pmc">PMC8767855</ArticleId><ArticleId IdType="pubmed">34849652</ArticleId></ArticleIdList></Reference><Reference><Citation>Batiha G.E.-S., Al-kuraishy H.M., Al-Gareeb A.I., Welson N.N. Pathophysiology of Post-COVID Syndromes: A New Perspective. Virol. J. 2022;19:158. doi: 10.1186/s12985-022-01891-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01891-2</ArticleId><ArticleId IdType="pmc">PMC9548310</ArticleId><ArticleId IdType="pubmed">36210445</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Ruiz J., Lomel&#xed;n-Gasc&#xf3;n J., Lira-Luna J., P&#xe9;rez-Fragoso A., Tapia-Conyer R., Nu&#xf1;ez-Aguirre M., Alcal&#xe1;-Carmona B., Absal&#xf3;n-Aguilar A., Maravillas-Montero J.L., Mej&#xed;a-Dom&#xed;nguez N.R., et al. FANSY POSTCOV: A Composite Clinical Immunological Predictive Index for Post-COVID-19 Syndrome Unveils Distinctive Features in a Cohort Study of Mild to Critical Patients. Clin. Transl. Med. 2021;11:e623. doi: 10.1002/ctm2.623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.623</ArticleId><ArticleId IdType="pmc">PMC8611773</ArticleId><ArticleId IdType="pubmed">34841707</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J., Wei L., Li G., Hua M., Sun Y., Wang D., Han K., Yan Y., Song C., Song R., et al. Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19. Front. Immunol. 2021;12:735125. doi: 10.3389/fimmu.2021.735125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.735125</ArticleId><ArticleId IdType="pmc">PMC8458852</ArticleId><ArticleId IdType="pubmed">34567001</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobcakova A., Petriskova J., Vysehradsky R., Kocan I., Kapustova L., Barnova M., Diamant Z., Jesenak M. Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome. Front. Cell. Infect. Microbiol. 2021;11:646688. doi: 10.3389/fcimb.2021.646688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.646688</ArticleId><ArticleId IdType="pmc">PMC8082075</ArticleId><ArticleId IdType="pubmed">33937096</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobcakova A., Barnova M., Vysehradsky R., Petriskova J., Kocan I., Diamant Z., Jesenak M. Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients. Front. Immunol. 2022;13:861666. doi: 10.3389/fimmu.2022.861666.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.861666</ArticleId><ArticleId IdType="pmc">PMC8982066</ArticleId><ArticleId IdType="pubmed">35392095</ArticleId></ArticleIdList></Reference><Reference><Citation>Garner L.C., Klenerman P., Provine N.M. Insights into Mucosal-Associated Invariant T Cell Biology from Studies of Invariant Natural Killer T Cells. Front. Immunol. 2018;9:1478. doi: 10.3389/fimmu.2018.01478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01478</ArticleId><ArticleId IdType="pmc">PMC6036249</ArticleId><ArticleId IdType="pubmed">30013556</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney J.P., Gao L. Proinflammatory Cytokines Increase Vascular Endothelial Growth Factor Expression in Alveolar Epithelial Cells. Mediat. Inflamm. 2015;2015:387842. doi: 10.1155/2015/387842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/387842</ArticleId><ArticleId IdType="pmc">PMC4573992</ArticleId><ArticleId IdType="pubmed">26424968</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan N.G., Aksakal &#x15e;., Y&#x131;lmam &#x130;., G&#xf6;rg&#xfc;n S. VEGF, IL-17 and IgG4 Levels of Patients with Lung Sequelae in Post-COVID-19 Period. Tuberk Toraks. 2022;70:179&#x2013;186. doi: 10.5578/tt.20229808.</Citation><ArticleIdList><ArticleId IdType="doi">10.5578/tt.20229808</ArticleId><ArticleId IdType="pubmed">35785882</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonny T.S., Patel E.U., Zhu X., Bloch E.M., Grabowski M.K., Abraham A.G., Littlefield K., Shrestha R., Benner S.E., Laeyendecker O., et al. Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma. Open Forum Infect. Dis. 2021;8:ofaa574. doi: 10.1093/ofid/ofaa574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa574</ArticleId><ArticleId IdType="pmc">PMC7717355</ArticleId><ArticleId IdType="pubmed">33553467</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi Y., Ge Y., Wu B., Zhang W., Wu T., Wen T., Liu J., Guo X., Huang C., Jiao Y., et al. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J. Infect. Dis. 2020;222:746&#x2013;754. doi: 10.1093/infdis/jiaa363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa363</ArticleId><ArticleId IdType="pmc">PMC7337752</ArticleId><ArticleId IdType="pubmed">32563194</ArticleId></ArticleIdList></Reference><Reference><Citation>Velikova T., Georgiev T. SARS-CoV-2 Vaccines and Autoimmune Diseases amidst the COVID-19 Crisis. Rheumatol. Int. 2021;41:509&#x2013;518. doi: 10.1007/s00296-021-04792-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04792-9</ArticleId><ArticleId IdType="pmc">PMC7846902</ArticleId><ArticleId IdType="pubmed">33515320</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency Safety of COVID-19 Vaccines.  [(accessed on 13 October 2022)].  Available online:  https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-COVID-19/treatments-vaccines/vaccines-COVID-19/safety-COVID-19-vaccines.</Citation></Reference><Reference><Citation>Garg R.K., Paliwal V.K. Spectrum of Neurological Complications Following COVID-19 Vaccination. Neurol. Sci. 2021;43:3&#x2013;40. doi: 10.1007/s10072-021-05662-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05662-9</ArticleId><ArticleId IdType="pmc">PMC8557950</ArticleId><ArticleId IdType="pubmed">34719776</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., Watkinson P., Khunti K., Harnden A., Coupland C.A.C., et al. Risks of Myocarditis, Pericarditis, and Cardiac Arrhythmias Associated with COVID-19 Vaccination or SARS-CoV-2 Infection. Nat. Med. 2021;28:410&#x2013;422. doi: 10.1038/s41591-021-01630-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Allahyari F., Molaee H., Hosseini Nejad J. COVID-19 Vaccines and Neurological Complications: A Systematic Review. Z. Naturforsch. C. 2022 doi: 10.1515/znc-2022-0092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/znc-2022-0092</ArticleId><ArticleId IdType="pubmed">36087300</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts K., Sidhu N., Russel M., Abbas M.J. Psychiatric Pathology Potentially Induced by COVID-19 Vaccine. Prog. Neurol. Psychiatry. 2021;25:8&#x2013;10. doi: 10.1002/pnp.723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pnp.723</ArticleId></ArticleIdList></Reference><Reference><Citation>Escudero C., Prieto-Monta&#xf1;o P., Audicana M.T. Adverse Reactions to Anti-Infective Vaccines: An Emerging Problem in the COVID-19 Era. Curr. Treat. Options Allergy. 2022;9:250&#x2013;272. doi: 10.1007/s40521-022-00311-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40521-022-00311-8</ArticleId><ArticleId IdType="pmc">PMC9244417</ArticleId><ArticleId IdType="pubmed">35789930</ArticleId></ArticleIdList></Reference><Reference><Citation>Won T., Gilotra N.A., Wood M.K., Hughes D.M., Talor M.V., Lovell J., Milstone A.M., Steenbergen C., &#x10c;ih&#xe1;kov&#xe1; D. Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 MRNA Vaccination. Front. Immunol. 2022;13:851620. doi: 10.3389/fimmu.2022.851620.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.851620</ArticleId><ArticleId IdType="pmc">PMC8894592</ArticleId><ArticleId IdType="pubmed">35251049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P., Gorelik Y., Zayyad H., Wertheim O., Wiegler K.B., Abu Jabal K., Dror A.A., Nazzal S., Glikman D., Edelstein M. Association between BNT162b2 Vaccination and Reported Incidence of Post-COVID-19 Symptoms: Cross-Sectional Study 2020-21, Israel. NPJ Vaccines. 2022;7:101. doi: 10.1038/s41541-022-00526-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00526-5</ArticleId><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Parperis K., Constantinou M. Remitting Seronegative Symmetrical Synovitis with Pitting Oedema Following BNT162b2 MRNA COVID-19 Vaccination. BMJ Case Rep. 2021;14:e244479. doi: 10.1136/bcr-2021-244479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-244479</ArticleId><ArticleId IdType="pmc">PMC8340295</ArticleId><ArticleId IdType="pubmed">34348912</ArticleId></ArticleIdList></Reference><Reference><Citation>Arino H., Muramae N., Okano M., Mori K., Otsui K., Sakaguchi K. Acute Onset of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Two Weeks after COVID-19 Vaccination with MRNA-1273 with Possible Activation of Parvovirus B19: A Case Report With Literature Review. Cureus. 2022;14:e24952. doi: 10.7759/cureus.24952.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.24952</ArticleId><ArticleId IdType="pmc">PMC9187273</ArticleId><ArticleId IdType="pubmed">35706724</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovaguimian A., Gibbons C.H. Diagnosis and Treatment of Pain in Small-Fiber Neuropathy. Curr. Pain Headache Rep. 2011;15:193&#x2013;200. doi: 10.1007/s11916-011-0181-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-011-0181-7</ArticleId><ArticleId IdType="pmc">PMC3086960</ArticleId><ArticleId IdType="pubmed">21286866</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams R.M.C., Simpson D.M., Navis A., Jette N., Zhou L., Shin S.C. Small Fiber Neuropathy Associated with SARS-CoV-2 Infection. Muscle Nerve. 2022;65:440&#x2013;443. doi: 10.1002/mus.27458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnihotri S.P., Luis C.V.S., Kazamel M. Autonomic Neuropathy as Post-Acute Sequela of SARS-CoV-2 Infection: A Case Report. J. Neurovirol. 2022;28:158&#x2013;161. doi: 10.1007/s13365-022-01056-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-022-01056-5</ArticleId><ArticleId IdType="pmc">PMC8856878</ArticleId><ArticleId IdType="pubmed">35181863</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Post COVID-19 Syndrome Associated with Orthostatic Cerebral Hypoperfusion Syndrome, Small Fiber Neuropathy and Benefit of Immunotherapy: A Case Report. Eneurologicalsci. 2020;21:100276. doi: 10.1016/j.ensci.2020.100276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2020.100276</ArticleId><ArticleId IdType="pmc">PMC7502253</ArticleId><ArticleId IdType="pubmed">32984564</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Mills A.J., Kelley M., Toran L.S., Smith B., Dalakas M.C., Nath A. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., Suarez M.D., Shelly S., Lamotte G.J., Sandroni P., Benarroch E.E., Berini S.E., Cutsforth-Gregory J.K., et al. Autonomic Dysfunction Following COVID-19 Infection: An Early Experience. Clin. Auton. Res. 2021;31:385&#x2013;394. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Schratzberger P., Walter D.H., Rittig K., Bahlmann F.H., Pola R., Curry C., Silver M., Krainin J.G., Weinberg D.H., Ropper A.H., et al. Reversal of Experimental Diabetic Neuropathy by VEGF Gene Transfer. J. Clin. Investig. 2001;107:1083&#x2013;1092. doi: 10.1172/JCI12188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI12188</ArticleId><ArticleId IdType="pmc">PMC209283</ArticleId><ArticleId IdType="pubmed">11342572</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya M. VEGF-VEGFR System as a Target for Suppressing Inflammation and Other Diseases. Endocr. Metab. Immune Disord. Targets. 2015;15:135&#x2013;144. doi: 10.2174/1871530315666150316121956.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871530315666150316121956</ArticleId><ArticleId IdType="pubmed">25772179</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Lu S., Li T., Yu L., Zhang Y., Zeng H., Qian X., Bi J., Lin Y. ACE2 Inhibits Breast Cancer Angiogenesis via Suppressing the VEGFa/VEGFR2/ERK Pathway. J. Exp. Clin. Cancer Res. 2019;38:173. doi: 10.1186/s13046-019-1156-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-019-1156-5</ArticleId><ArticleId IdType="pmc">PMC6482513</ArticleId><ArticleId IdType="pubmed">31023337</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Nan B., Yan S., Li M., Yao Q., Chen C. C-Reactive Protein Decreases Expression of VEGF Receptors and Neuropilins and Inhibits VEGF165-Induced Cell Proliferation in Human Endothelial Cells. Biochem. Biophys. Res. Commun. 2005;333:1003&#x2013;1010. doi: 10.1016/j.bbrc.2005.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.06.014</ArticleId><ArticleId IdType="pubmed">15975559</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Fern&#xe1;ndez E., Egia-Mendikute L., Vila-Vecilla L., Bosch A., Barreira-Manrique A., Lee S.Y., Garc&#xed;a-del R&#xed;o A., Anto&#xf1;ana-Vildosola A., Jim&#xe9;nez-Lasheras B., Moreno-Cugnon L., et al. Hypoxia Reduces Cell Attachment of SARS-CoV-2 Spike Protein by Modulating the Expression of ACE2, Neuropilin-1, Syndecan-1 and Cellular Heparan Sulfate. Emerg. Microbes Infect. 2021;10:1065&#x2013;1076. doi: 10.1080/22221751.2021.1932607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1932607</ArticleId><ArticleId IdType="pmc">PMC8183554</ArticleId><ArticleId IdType="pubmed">34013835</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Wei Q., Lin Q., Fang J., Wang H., Kwok H., Tang H., Nishiura K., Peng J., Tan Z., et al. Anti-Spike IgG Causes Severe Acute Lung Injury by Skewing Macrophage Responses during Acute SARS-CoV Infection. JCI Insight. 2019;4:e123158. doi: 10.1172/jci.insight.123158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123158</ArticleId><ArticleId IdType="pmc">PMC6478436</ArticleId><ArticleId IdType="pubmed">30830861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D.O., Catalano P.J., Symonds K.E., Varey A.H.R., Ramani P., O&#x2019;Dwyer P.J., Giantonio B.J., Meropol N.J., Benson A.B., Harper S.J. Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab. Clin. Cancer Res. 2012;18:6384&#x2013;6391. doi: 10.1158/1078-0432.CCR-12-2223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-12-2223</ArticleId><ArticleId IdType="pmc">PMC3602975</ArticleId><ArticleId IdType="pubmed">23104894</ArticleId></ArticleIdList></Reference><Reference><Citation>Hormbrey E., Gillespie P., Turner K., Han C., Roberts A., McGrouther D., Harris A.L. A Critical Review of Vascular Endothelial Growth Factor (VEGF) Analysis in Peripheral Blood: Is the Current Literature Meaningful? Clin. Exp. Metastasis. 2002;19:651&#x2013;663. doi: 10.1023/A:1021379811308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1021379811308</ArticleId><ArticleId IdType="pubmed">12553370</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>